InvestorsHub Logo
Followers 38
Posts 1440
Boards Moderated 0
Alias Born 03/07/2004

Re: ralphazard post# 131213

Wednesday, 07/03/2013 11:26:30 PM

Wednesday, July 03, 2013 11:26:30 PM

Post# of 345952
ralphazard, extremely timely reminder about Bavituximab potential in hepatocellular cancer. I would expect results similar to those we will find with Bavi and irradiation therapy, and with the latter I would expect dosage levels of Bavi of approximately what is being used for HCC with sorafenib (3mg/kg.)
That's a lotta Bavi.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News